Lynx Investment Advisory Bio Rad Laboratories, Inc. Call Options Transaction History
Lynx Investment Advisory
- $135 Billion
- Q2 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding BIO
# of Institutions
461Shares Held
20.2MCall Options Held
23.2KPut Options Held
37.4K-
Vanguard Group Inc Valley Forge, PA2.37MShares$875 Million0.01% of portfolio
-
Black Rock Inc. New York, NY1.55MShares$571 Million0.01% of portfolio
-
Van Eck Associates Corp1.3MShares$480 Million0.55% of portfolio
-
Veritas Asset Management LLP1.09MShares$400 Million3.03% of portfolio
-
State Street Corp Boston, MA860KShares$317 Million0.01% of portfolio
About BIO-RAD LABORATORIES, INC.
- Ticker BIO
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 24,633,900
- Market Cap $9.08B
- Description
- Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...